Volume Alert: Shares of Cord Blood America, Inc. (OTCBB: CBAI), an umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells, to families nationwide and internationally, surged more than 10% last week on five times average volume, after the company announced that all preliminary due diligence is now complete for the acquisition of a controlling interest in BioCells, Inc. BioCells is the second largest stem cell storage company in Argentina, with 12 locations throughout that nation of 40 million people, plus recent expansion into Uruguay and Paraguay. The company is also in the process of developing affiliationsin Peru, Colombia, Bolivia, Panama and Puerto Rico. BioCells reported annual revenues in 2009 of $1.2 million. A letter of intent had been signed by both companies for Cord Blood America to purchase a controlling interest in BioCells, before August 31, 2010. CBAI also also announced last week that it has begun its continuing education program for the nation's 2.9 million registered nurses on the value of cord blood collection as a potentially life-saving resource for treating serious diseases. Recently, the first two courses were held in Pennsylvania and West Virginia, with additional courses planned in various states in the upcoming months. The company is supporting the Mandatory Continuing Education Law, Act 58, by helping nurses take advantage of planned learning opportunities. Shares of CBAI closed out the week at $0.01.
Don't worry about the mule going blind just load the wagon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.